Patent: 10,577,641
✉ Email this page to a colleague
Summary for Patent: 10,577,641
Title: | Truncated Her2 SRM/MRM assay |
Abstract: | This disclosure provides ten (10) specific peptides, and particular peptide characteristics, from the cell membrane-bound Her2 protein and a diagnostic assay useful for determining the presence and amount of full length and truncated versions of the full-length Her2 protein in cells derived from formalin fixed paraffin embedded tissue. |
Inventor(s): | Krizman; David (Gaithersburg, MD) |
Assignee: | EXPRESSION PATHOLOGY, INC. (Rockville, MD) |
Application Number: | 15/707,283 |
Patent Claims: | see list of patent claims |
Details for Patent 10,577,641
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2030-12-08 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2030-12-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |